Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$521M |
| 2 |
Nike
NKE
|
+$509M |
| 3 |
Micron Technology
MU
|
+$439M |
| 4 |
Super Micro Computer
SMCI
|
+$435M |
| 5 |
Broadcom
AVGO
|
+$329M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$5.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.89B |
| 3 |
Amazon
AMZN
|
+$1.48B |
| 4 |
Microsoft
MSFT
|
+$1.07B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93% |
| 2 | Technology | 2.38% |
| 3 | Consumer Discretionary | 1.03% |
| 4 | Financials | 0.75% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10551
Algoma Steel
ASTL
$453M
| $162K | ﹤0.01% |
+23,228
| New | +$179K |
|
|
TSVT
10552
DELISTED
2seventy bio
TSVT
| $162K | ﹤0.01% |
41,979
+8,944
| +27% | +$40.3K |
|
10553
PUT
Akebia Therapeutics
AKBA
$260M
| $161K | ﹤0.01% |
158,300
-39,400
| -20% | -$48.7K |
|
10554
PUT
Voyager Therapeutics
VYGR
$213M
| $161K | ﹤0.01% |
20,400
-16,500
| -45% | -$138K |
|
10555
CALL
SkinHealth Systems
SKIN
$90M
| $161K | ﹤0.01% |
84,000
-260,300
| -76% | -$733K |
|
10556
Envela
ELA
$362M
| $161K | ﹤0.01% |
35,911
-5,805
| -14% | -$26.4K |
|
10557
PUT
Allogene Therapeutics
ALLO
$722M
| $161K | ﹤0.01% |
69,200
+38,500
| +125% | +$114K |
|
10558
Veritone
VERI
$82.4M
| $161K | ﹤0.01% |
71,268
+50,781
| +248% | +$180K |
|
10559
Hudbay
HBM
$13.5B
| $161K | ﹤0.01% |
+17,768
| New | +$154K |
|
|
NFGC
10560
CALL
New Found Gold
NFGC
$749M
| $161K | ﹤0.01% |
56,800
+13,900
| +32% | +$49K |
|
|
ZH
10561
PUT
Zhihu
ZH
$260M
| $161K | ﹤0.01% |
+58,800
| New | +$216K |
|
|
VRE
10562
PUT
DELISTED
Veris Residential
VRE
| $161K | ﹤0.01% |
+10,700
| New | +$160K |
|
10563
PUT
Daktronics
DAKT
$947M
| $160K | ﹤0.01% |
11,500
-38,100
| -77% | -$407K |
|
|
RVPH
10564
CALL
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $160K | ﹤0.01% |
6,265
-3,895
| -38% | -$177K |
|
10565
Lightbridge
LTBR
$306M
| $160K | ﹤0.01% |
47,480
+20,705
| +77% | +$55.5K |
|
|
ALCY
10566
DELISTED
Alchemy Investments Acquisition Corp 1
ALCY
| $160K | ﹤0.01% |
+14,890
| New | +$159K |
|
10567
iQIYI
IQ
$892M
| $160K | ﹤0.01% |
+43,529
| New | +$196K |
|
10568
Broadway Financial
BYFC
$112M
| $160K | ﹤0.01% |
31,075
-1,858
| -6% | -$9.35K |
|
|
VZLA
10569
Vizsla Silver
VZLA
$1.46B
| $160K | ﹤0.01% |
+89,177
| New | +$140K |
|
10570
ProQR Therapeutics
PRQR
$327M
| $160K | ﹤0.01% |
96,118
-44,033
| -31% | -$85.5K |
|
10571
CALL
Innoviz Technologies
INVZ
$106M
| $159K | ﹤0.01% |
171,500
-293,100
| -63% | -$329K |
|
10572
PUT
Genworth Financial
GNW
$3.75B
| $159K | ﹤0.01% |
26,400
-9,500
| -26% | -$59.1K |
|
10573
CALL
Invesco Financial Preferred ETF
PGF
$661M
| $159K | ﹤0.01% |
10,800
-10,800
| -50% | -$159K |
|
|
KGEI
10574
Kolibri Global Energy
KGEI
$210M
| $159K | ﹤0.01% |
44,551
+22,317
| +100% | +$74K |
|
|
HIE
10575
DELISTED
Miller/Howard High Income Equity Fund
HIE
| $159K | ﹤0.01% |
+14,185
| New | +$157K |
|
Similar funds
Jeff Yass's Q2 2024 Portfolio in Review
As of Q2 2024, Jeff Yass held 13,638 positions worth $537B, down 6.7% from $576B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q2 2024 filing shows 1,591 new, 4,593 increased, 5,607 reduced and 1,726 closed positions. Its largest new stake was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M. The largest sale was NVIDIA, an estimated $5.31B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2024 buy was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M.
- Jeff Yass added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $521M increase.
- Jeff Yass's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $5.31B.
- Jeff Yass fully exited iShares MSCI USA Quality Factor ETF in Q2 2024, selling an estimated $26.2M.
- Jeff Yass's ten largest holdings make up 26% of its $537B portfolio in Q2 2024.
- Jeff Yass opened 1,591 new positions and closed 1,726 in Q2 2024.
- Jeff Yass's portfolio value fell 6.7% quarter-over-quarter to $537B.
Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.